Skip to content
Disclosery

Medicxi Ventures Management (Jersey) Ltd

Follow

13F filer, CIK 1715579, ST. HELIER, Jersey

Medicxi Ventures Management (Jersey) Ltd reported $834,980,337 across 5 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-01-23.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-020931

Period
2025-12-31
Reported value
$835M
Holdings
5
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001193125-26-020931, largest first. % of portfolio is the value over $834,980,337, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 19,963,157 shares; 2024Q4: 19,963,157 shares; 2025Q1: 19,963,157 shares; 2025Q2: 19,963,157 shares; 2025Q3: 19,963,157 shares; 2025Q4: 19,963,157 shares 19,963,157$499M59.8%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,464,572 shares; 2024Q4: 7,464,572 shares; 2025Q1: 7,464,572 shares; 2025Q2: 7,464,572 shares; 2025Q3: 7,464,572 shares; 2025Q4: 7,464,572 shares 7,464,572$124M14.83%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,869,565 shares; 2024Q4: 2,869,565 shares; 2025Q1: 2,869,565 shares; 2025Q2: 2,869,565 shares; 2025Q3: 2,869,565 shares; 2025Q4: 2,869,565 shares 2,869,565$101M12.06%0Timeline
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 22,352,000 shares; 2025Q1: 22,352,000 shares; 2025Q2: not reported; 2025Q3: 2,794,000 shares; 2025Q4: 2,794,000 shares 2,794,000$94.6M11.33%0
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,039,892 shares; 2024Q4: 3,039,892 shares; 2025Q1: 3,039,892 shares; 2025Q2: 3,039,892 shares; 2025Q3: 3,039,892 shares; 2025Q4: 3,039,892 shares 3,039,892$16.6M1.98%0Timeline

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-020931 base2026-01-23acceptance time not in the bulk data set